{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:57:31Z","timestamp":1793750251438,"version":"4.6.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Asana Biosciences"},{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Dermavant"},{"name":"DS Biopharma"},{"DOI":"10.13039\/501100009754","name":"Galderma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009754","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Glenmark"},{"name":"Innovaderm"},{"DOI":"10.13039\/100005565","name":"Janssen Biotech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005565","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Leo Pharma"},{"name":"Novan"},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ralexar"},{"DOI":"10.13039\/100009857","name":"Regeneron","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Union Therapeutic"},{"name":"Janssen"},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Boehringer Ingelheim"},{"name":"Dexcel Pharma"},{"name":"Janssen"},{"DOI":"10.13039\/100004312","name":"Lilly","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Neopharm"},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Perrigo"},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Rafa"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.jaip.2020.01.052","type":"journal-article","created":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T11:52:09Z","timestamp":1580989929000},"page":"1323-1328.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Alopecia Areata Is Associated with Atopic Diathesis: Results from a Population-Based Study of 51,561 Patients"],"prefix":"10.1016","volume":"8","author":[{"given":"Khalaf","family":"Kridin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Renert-Yuval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Guttman-Yassky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnon D.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2020.01.052_bib1","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jaad.2006.05.008","article-title":"Alopecia areata: a long term follow-up study of 191 patients","volume":"55","author":"Tosti","year":"2006","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2020.01.052_bib2","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4065\/70.7.628","article-title":"Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989","volume":"70","author":"Safavi","year":"1995","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaip.2020.01.052_bib3","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1056\/NEJMra1103442","article-title":"Alopecia areata","volume":"366","author":"Gilhar","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2020.01.052_bib4","article-title":"Association between alopecia areata, anxiety, and depression: a systematic review and meta-analysis [published online ahead of print June 1, 2019]","author":"Okhovat","year":"2019","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2020.01.052_bib5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5021\/ad.2013.25.1.12","article-title":"Combination therapy with cyclosporine and psoralen plus ultraviolet a in the patients with severe alopecia areata: a retrospective study with a self-controlled design","volume":"25","author":"Park","year":"2013","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.jaip.2020.01.052_bib6","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1001\/archderm.1992.01680210045005","article-title":"Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata","volume":"128","author":"Olsen","year":"1992","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2020.01.052_bib7","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1365-4632.2010.04576.x","article-title":"Could azathioprine be considered as a therapeutic alternative in the treatment of alopecia areata? A pilot study","volume":"49","author":"Farshi","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaip.2020.01.052_bib8","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1365-2133.2012.10955.x","article-title":"British Association of Dermatologists\u2019 guidelines for the management of alopecia areata 2012","volume":"166","author":"Messenger","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2020.01.052_bib9","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1080\/14712598.2016.1188076","article-title":"A\u00a0novel therapeutic paradigm for patients with extensive alopecia areata","volume":"16","author":"Renert-Yuval","year":"2016","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.jaip.2020.01.052_bib10","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1007\/s12325-017-0542-7","article-title":"The changing landscape of alopecia areata: the therapeutic paradigm","volume":"34","author":"Renert-Yuval","year":"2017","journal-title":"Adv Ther"},{"key":"10.1016\/j.jaip.2020.01.052_bib11","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.jisp.2017.10.014","article-title":"Hair follicle immune privilege revisited: the key to alopecia areata management","volume":"19","author":"Paus","year":"2018","journal-title":"J\u00a0Investig Dermatol Symp Proc"},{"key":"10.1016\/j.jaip.2020.01.052_bib12","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.3645","article-title":"Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition","volume":"20","author":"Xing","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.jaip.2020.01.052_bib13","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/bjd.16808","article-title":"Alopecia areata: a review of disease pathogenesis","volume":"179","author":"Rajabi","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2020.01.052_bib14","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.jid.2019.03.620","article-title":"544 Alopecia areata lesions show significant changes in immune and keratin biomarkers that correlate with clinical improvement with oral Janus kinase inhibitors PF-06651600 (JAK3) and PF-06700841 (TYK2\/JAK1)","volume":"139","author":"Guttman-Yassky","year":"2019","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2020.01.052_bib15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ebiom.2015.02.015","article-title":"Reversal of alopecia areata following treatment with the JAK1\/2 inhibitor baricitinib","volume":"2","author":"Jabbari","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jaip.2020.01.052_bib16","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.jid.2018.01.032","article-title":"An open-label pilot study to evaluate the efficacy of tofacitinib in moderate to severe patch-type alopecia areata, totalis, and universalis","volume":"138","author":"Jabbari","year":"2018","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2020.01.052_bib17","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jaci.2015.06.032","article-title":"Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17\/TH22 skewing","volume":"136","author":"Suarez-Farinas","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.052_bib18","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jdermsci.2014.11.009","article-title":"The PDE4 inhibitor, apremilast, suppresses experimentally induced alopecia areata in human skin in\u00a0vivo","volume":"77","author":"Keren","year":"2015","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jaip.2020.01.052_bib19","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1038\/sj.jid.5700915","article-title":"Loss-of-function mutations in the filaggrin gene and alopecia areata: strong risk factor for a severe course of disease in patients comorbid for atopic disease","volume":"127","author":"Betz","year":"2007","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2020.01.052_bib20","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4103\/2229-5178.131076","article-title":"Total serum immunoglobulin E in patients with alopecia areata","volume":"5","author":"Bakry","year":"2014","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.jaip.2020.01.052_bib21","first-page":"130","article-title":"Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease-associated psychological morbidity","volume":"182","author":"Bain","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2020.01.052_bib22","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1038\/jid.2012.129","article-title":"Follow-up study of the first genome-wide association scan in alopecia areata: IL13 and KIAA0350 as susceptibility loci supported with genome-wide significance","volume":"132","author":"Jagielska","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2020.01.052_bib23","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.gene.2013.05.086","article-title":"The association between interleukin (IL)-4 gene intron 3 VNTR polymorphism and alopecia areata (AA) in Turkish population","volume":"527","author":"Kalkan","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.jaip.2020.01.052_bib24","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jaad.2009.04.031","article-title":"History of atopy or autoimmunity increases risk of alopecia areata","volume":"61","author":"Barahmani","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2020.01.052_bib25","doi-asserted-by":"crossref","first-page":"722","DOI":"10.5021\/ad.2014.26.6.722","article-title":"Differences in comorbidity profiles between early-onset and late-onset\u00a0alopecia areata patients: a retrospective study of 871 Korean patients","volume":"26","author":"Lee","year":"2014","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.jaip.2020.01.052_bib26","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jaad.2010.08.032","article-title":"Comorbidity profiles among patients with alopecia areata: the importance of onset age, a nationwide population-based study","volume":"65","author":"Chu","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2020.01.052_bib27","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/jamadermatol.2013.3049","article-title":"Autoimmune, atopic, and mental health comorbid conditions associated with alopecia areata in the United States","volume":"149","author":"Huang","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaip.2020.01.052_bib28","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jaad.2018.07.013","article-title":"Comorbidities in alopecia areata: a systematic review and meta-analysis","volume":"80","author":"Lee","year":"2019","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2020.01.052_bib29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.det.2018.12.007","article-title":"What\u2019s new in atopic dermatitis","volume":"37","author":"Renert-Yuval","year":"2019","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaip.2020.01.052_bib30","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/all.13128","article-title":"Incident alopecia areata and vitiligo in adult women with atopic dermatitis: Nurses\u2019 Health Study 2","volume":"72","author":"Drucker","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.01.052_bib31","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jaad.2018.07.044","article-title":"Association of alopecia areata with hospitalization for mental health disorders in US adults","volume":"80","author":"Singam","year":"2019","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2020.01.052_bib32","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/ACI.0000000000000204","article-title":"Epidemiology of allergic conjunctivitis: clinical appearance and treatment patterns in a population-based study","volume":"15","author":"Leonardi","year":"2015","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.052_bib33","first-page":"751","article-title":"Alopecia areata, part 1: pathogenesis, diagnosis, and prognosis","volume":"61","author":"Spano","year":"2015","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.jaip.2020.01.052_bib34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1479-5876-9-129","article-title":"Anti-inflammatory effects of nicotine in obesity and ulcerative colitis","volume":"9","author":"Lakhan","year":"2011","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.jaip.2020.01.052_bib35","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s12026-018-9021-8","article-title":"Cigarette smoking associates inversely with a cluster of two autoimmune diseases: ulcerative colitis and pemphigus","volume":"66","author":"Kridin","year":"2018","journal-title":"Immunol Res"},{"key":"10.1016\/j.jaip.2020.01.052_bib36","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/jamadermatol.2019.0629","article-title":"All-cause and cause-specific mortality risks associated with alopecia areata: a Korean nationwide population-based study","volume":"155","author":"Lee","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaip.2020.01.052_bib37","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.jaci.2017.04.004","article-title":"Novel concepts of prevention and treatment of atopic dermatitis through barrier and immune manipulations with implications for the atopic march","volume":"139","author":"Czarnowicki","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.052_bib38","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(16)30307-5","article-title":"Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting beta2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial","volume":"388","author":"Wenzel","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2020.01.052_bib39","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1016\/S0140-6736(17)31191-1","article-title":"Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial","volume":"389","author":"Blauvelt","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2020.01.052_bib40","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1016\/j.jaip.2019.03.023","article-title":"Dupilumab improves patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma","volume":"7","author":"Bachert","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2020.01.052_bib41","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1346-8138.2009.00647.x","article-title":"Fexofenadine hydrochloride enhances the efficacy of contact immunotherapy for extensive alopecia areata: retrospective analysis of 121 cases","volume":"36","author":"Inui","year":"2009","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.jaip.2020.01.052_bib42","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1346-8138.2012.01571.x","article-title":"Case of intractable ophiasis type of alopecia areata presumably improved by fexofenadine","volume":"39","author":"Nonomura","year":"2012","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.jaip.2020.01.052_bib43","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jdermsci.2010.03.009","article-title":"Experimental evaluation of ebastine, a second-generation anti-histamine, as a supportive medication for alopecia areata","volume":"58","author":"Ohyama","year":"2010","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jaip.2020.01.052_bib44","doi-asserted-by":"crossref","first-page":"72","DOI":"10.12788\/j.sder.2015.0160","article-title":"Alopecia areata update","volume":"34","author":"Hordinsky","year":"2015","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.jaip.2020.01.052_bib45","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/all.13346","article-title":"Alopecia areata is characterized by expansion of circulating Th2\/Tc2\/Th22, within the skin-homing and systemic T-cell populations","volume":"73","author":"Czarnowicki","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.01.052_bib46","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.jaci.2018.06.029","article-title":"An integrated model of alopecia areata biomarkers highlights both TH1 and TH2 upregulation","volume":"142","author":"Song","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.052_bib47","doi-asserted-by":"crossref","first-page":"e296","DOI":"10.1111\/jdv.15571","article-title":"Hair regrowth and dissemination of molluscum contagiosum: two unexpected effects with dupilumab","volume":"33","author":"Sevray","year":"2019","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2020.01.052_bib48","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jdcr.2018.11.007","article-title":"Remission of alopecia universalis in a patient with atopic dermatitis treated with dupilumab","volume":"5","author":"Smogorzewski","year":"2019","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jaip.2020.01.052_bib49","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/jamadermatol.2018.2976","article-title":"Hair regrowth in a patient with long-standing alopecia totalis and atopic dermatitis treated with dupilumab","volume":"154","author":"Penzi","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaip.2020.01.052_bib50","first-page":"139","article-title":"Alopecia universalis and atopic dermatitis improvement with dupilumab: demonstration of a shared pathophysiology and clinical efficacy","volume":"17","author":"Dobkin","year":"2019","journal-title":"Skinmed"},{"key":"10.1016\/j.jaip.2020.01.052_bib51","article-title":"Cause or cure? Review of dupilumab and alopecia areata [published online ahead of print June 13, 2019]","author":"Marks","year":"2019","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2020.01.052_bib52","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jdcr.2019.03.019","article-title":"Alopecia areata in 2 patients treated with dupilumab: new onset and worsening","volume":"5","author":"Chung","year":"2019","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jaip.2020.01.052_bib53","article-title":"Reactivation of alopecia areata after dupilumab therapy for atopic dermatitis [published online ahead of print August 21, 2019]","author":"Carnicle","year":"2019","journal-title":"Dermatitis"},{"key":"10.1016\/j.jaip.2020.01.052_bib54","doi-asserted-by":"crossref","first-page":"e12869","DOI":"10.1111\/dth.12869","article-title":"Development of alopecia in patients treated with dupilumab","volume":"32","author":"Maloney","year":"2019","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaip.2020.01.052_bib55","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0140-6736(18)32987-8","article-title":"JAK inhibitors and alopecia areata","volume":"393","author":"Gilhar","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2020.01.052_bib56","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/j.1365-2133.2009.09398.x","article-title":"Coeliac disease associated with psoriasis","volume":"161","author":"Birkenfeld","year":"2009","journal-title":"Br J Dermatol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219820301392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219820301392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:23:08Z","timestamp":1761974588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219820301392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S2213219820301392"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2020.01.052","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alopecia Areata Is Associated with Atopic Diathesis: Results from a Population-Based Study of 51,561 Patients","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2020.01.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}